
Ascendis Pharma AS
ASNDHealthcare|Biotechnology|Denmark
$270.51
-5.15 (-1.87%)
Tangible Book
$9.06
Graham Number
$44.64
About
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Stock Price
+10.2%(1Y)
Pipeline Summary
0 total trials0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
BioScore
5.8/10
Watchlist
Ownership
Recent Insider Trades
SMITH SCOTT THOMASBUY
2026-06-02100 shares @ $219
BIENAIME JEAN JACQUESBUY
2026-05-29500 shares @ $223.12
SMITH SCOTT THOMASBUY
2026-05-29250 shares @ $223.32
BIENAIME JEAN JACQUESBUY
2026-05-26400 shares @ $237.8
JENSEN FLEMMING STEENSELL
2026-05-1119,460 shares @ $238.49
Recent News
2026-07-07 16:33:53
2026-06-30 13:32:41
2026-06-26 21:55:54
2026-06-26 20:50:24
2026-06-14 21:27:37
Data last updated: Jul 12, 2026, 07:28 PM